Carnisone increases efficiency of DOPA therapy of Parkinson's disease: A pilot study

Rejuvenation Research

Volumn 11, Issue 4, 2008, Pages 821-827

  Boldyrev, Alexander ^a,b   Fedorova, Tatiana ^a   Stepanova, Maria ^a   Dobrotvorskaya, Irina ^a   Kozlova, Eugenia ^a   Boldanova, Natalia ^b,c   Bagyeva, Gulbakhar ^a   Ivanova Smolenskaya, Irina ^a   Illarioshkin, Serguey ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c BAIKAL INSTITUTE OF NATURE MANAGEMENT   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBONYL DERIVATIVE; CARNOSINE; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROPEROXIDE DERIVATIVE; LEVODOPA; PIRIBEDIL; PRAMIPEXOLE; SEVITINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE;

ADULT; AGED; CARNOSINE; DIHYDROXYPHENYLALANINE; DRUG SYNERGISM; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; OXIDATIVE STRESS; PARKINSON DISEASE; PILOT PROJECTS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 50449098572     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0716     Document Type: Article

References (30)

1. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-272.
2. Samii A, Nut JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1783-1793.
3. Cookson M. The biochemistry of Parkinson's disease. Annu Rev Biochem 2005;74:29-52.
4. Wolters ECh, van Laar T, Berendse HW. Parkinsonism and Related Disorders. VU University Press, Amsterdam, 2007.
5. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003;302:819-822.
6. Illarioshkin SN. The conformation diseases of the brain. Yanus-K, Moscow, [in Russian]. 2002.
7. Olanov CW. A radical hypothesis of neurodegeneration. Trends Neurosci 1993;16:439-444.
8. Mouradian MM. Recent advances in the genetics and pathogenesis Parkinson's disease. Neurology 2002;58:179-185.
9. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996;47(suppl3):S161-170.
10. Abraham S, Soundararajan CC, Vivekanandhan S, Behari M. Erythrocyte antioxidant enzymes in Parkinson's disease. Ind J Med Res 2005;121:111-115.
11. Youdim M, Geldenhuys W, van der Schyf C. Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease? Parkinsonism Rel Disor 2007;13:S281-291.
12. Hirsch EC. How to improve neuroprotection in Parkinson's disease? Parkinsonism Rel Disor 2007;13:S332-335.
13. Boldyrev A. Carnosine and oxidative stress in cells and tissues. Nova Science, New York, 2006.
14. Dobrota D, Fedorova T, Stvolinsky S, Babusikova E, Likavcanova K, Drgova A, Strapkova A, Boldyrev A. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res 2005;30:1283-1288.
15. Choi SY, Kwon HY, Kwon OB, Kang JH. Hydrogen peroxide-mediated Cu,Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine. Biochim Biophys Acta 1999;1472:651-657.
16. Hipkiss A. Could carnosine or related structures suppress Alzheimer's disease? J Alz Dis 2007;11:229-240.
17. Stvolinsky SL, Fedorova TN, Yuneva MO, Boldyrev AA. Protective effect of carnosine on Cu,Zn-superoxide dismutase during impaired oxidative metabolism in the brain in vivo. Bull Exp Biol Med 2003;135(2):151-154.
18. Boldyrev AA, Fedorova TN, Stvolinsky SL, Borras C, Sastre J, Vina J. Chemical intervention in senescence-accelerated mice metabolism for modeling neurodegenerative diseases: an overview. In: Nomura Y. (Ed.), Senescence-Accelerated Mouse (SAM): An Animal Model of Senescence. Elsevier, Amsterdam, 2004.
19. Boldyrev A, Fedorova T, Stvolinsky S, Stepanova M, Dobrotvorskaya I, Kozlova E, Bagyeva G, Ivanova-Smolenskaya I, Markova E, Illarioshkin S. Carnosine increases efficiency of L-DOPA therapy of parkinsonics. Parkinsonism Rel Disor 2007;13:S99.
20. Fahn S, Elton R. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease. In: S. Fahn, C. Marsden, D. Calne, M. Goldstein (Eds.), McMillan Healthcare Information. 1987;2:153-163: http://www.mdvu.org/library/ratingscales/pd/
21. Vetreshchak TV, Poleshchuk VV, Ivanova-Smolenskaya IA, Markova ED, Stvolinsky SL, Kramarenko GG. Monoamine oxidase B and Cu/Zn-superoxide dismutase of peripheral blood at Parkinson disease. Neurochemistry (Russian) 2002;19(3):213-218.
22. Misra HP, Fridovich J. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. Biochemistry 1972;247:3170-3175.
23. Winterbourn CC, Buss IH, Chan TP, Plank LD, Clark MA, Windsor JA. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 2000; 28(1):143-149.
24. Fedorova TN, Boldyrev AA, Gannushkina IV. Lipid peroxidation in experimental ischemia of the brain. Biochemistry (Moscow) 1999;64:75-79.
25. Glantz S. Primer of Biostatistics. McGraw-Hill, New York, 1994.
26. Götz ME, Freyberger A, Riederer P. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J Neural Transm 1990;29:241-249.
27. Serra JA, Dominguez RO, de Lustig ES, Guareschi EM, Famulari AL, Bartolome EL, Marschoff ER. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm 2001;108(10):1135- 1148.
28. Seidler NV, Yeargans GS, Morgan TG. Carnosine disaggregates glycated α-crystallin: an in vitro study. Arch Biochem Biophys 2004;427:110-115.
29. Yan H, Harding JJ. Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochim Biophys Acta 2005;1741:120-126.
30. Yasuhara T, Hara K, Maki M, Masuda T, Sanberg CD, Sanberg PR, Bickford PC, Borlongan CV. Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Res 2008;11(1):201-214.